sutures newsletter

PRODUCED BY AND FOR MEMBERS OF THE DEPARTMENT OF SURGERY October 2016 | Archived Issues

Mark Your Calendar


Surgery Grand Rounds

Click the "read more" to see information about upcoming Surgery Grand Rounds.


Grand Rounds

Click here to view a schedule of all upcoming grand rounds.


Education Schedule

Click the PDF links below to see the Department of Surgery's education schedule.

Education Schedule - October 2016 (PDF)  

Education Schedule - November 2016 (PDF)  


Surgery Scheduling

Click the "read more" for hours and contact information for surgery scheduling.

Share Your News

Know an interesting colleague we should profile? A story we should tell? Submit your ideas, meetings and events for consideration.

Click here to submit your news to Sutures

Figlin to Lead Initiative to Integrate Cancer Care

Robert A. Figlin, MD

Robert A. Figlin, MD

In an effort to standardize cancer care and ensure optimal treatment of patients, Cedars-Sinai has appointed Robert A. Figlin, MD, to integrate research and clinical strategies across the organization.

Figlin will serve as deputy director of the Integrated Oncology Service Line at the Samuel Oschin Comprehensive Cancer Institute. Previously, he was director of the Hematology Oncology Division at the institute. He will remain in this position until a successor can be found.

In his new role, Figlin will work with clinicians and investigators to unify the health system’s approach to treating cancer. The integration of cancer care means that patients will get the same level of quality services whether they’re treated at Cedars-Sinai’s main campus or at one of its highly regarded affiliates, including Tower Hematology Oncology and The Angeles Clinic.

"Dr. Figlin was tailor-made to do this," said Steven Piantadosi, MD, PhD, director of the Samuel Oschin Comprehensive Cancer Institute and professor of Medicine at Cedars-Sinai. "He’s an experienced leader who knows cancer care in the Cedars-Sinai system, throughout Los Angeles and beyond."

A kidney cancer specialist, Figlin will continue working to develop clinical trials, translate research findings from the laboratory to the clinical setting and lead initiatives such as Cedars-Sinai’s effort to contain the high cost of cancer drugs.

Figlin, who joined Cedars-Sinai six years ago, is the Steven Spielberg Family Chair in Hematology Oncology. Since his arrival, he has established the Experimental Therapeutics Program and successfully recruited clinical and research faculty in critical specialty areas such as breast cancer, bone marrow transplant, gastrointestinal oncology, genitourinary oncology, survivorship and cancer biology, among many other achievements.

His new position, he says, will provide additional opportunities to enhance the lives of cancer patients, while advancing significant research goals.

"This position presents an opportunity to improve cancer care for our patients at Cedars-Sinai," Figlin said. "Contributing to cancer science allows me to wake up each day and feel as though I’m making an important difference."